Life Sciences
The FierceMarkets Life Science group reaches over 120,000 leading professionals focused on the development and distribution of new drugs. This targeted audience includes executives at Biotech and Pharma companies, lab researchers, and others who shape the industry.
Looking for a unique way to reach a highly targeted Life Science audience? Check out our special packages and upcoming editorial calendar.
| Overview: | Coverage of the biotech and life science industry. | |
| Audience: | Senior executives and business decision makers at biotech, pharmaceutical, and related drug development companies. | |
| Channels: | Daily email newsletter, Website, Webinars, Events | |
| Email Subscribers: | 65,000+ | |
| Monthly Web PVs: | 280,000 | |
| Lead Editor: | John D. Carroll and Maureen Martino |
| Overview: | Industry news including changes in regulations, corporate earnings, post-marketing issues, contract manufacturing and more. | |
| Audience: | Senior pharmaceutical industry executives, project managers, and other business decision makers at pharmaceutical and related life sciences companies. | |
| Channels: | Daily email newsletter, Website, Webinars, Events | |
| Email Subscribers: | 20,000+ | |
| Monthly Web PVs: | 100,000 | |
| Lead Editor: | Tracy Staton and Maureen Martino |
| Overview: | News for biotech research scientists, lab supervisors, and principal investigators. | |
| Audience: | Research scientists, lab supervisors, principal investigators and others involved in the field of human drug development. | |
| Channels: | Weekly email newsletter, Website, Webinars, Events | |
| Email Subscribers: | 25,000+ | |
| Monthly Web PVs: | 25,000 | |
| Lead Editor: | John D. Carroll |
| Overview: | Examines the people, trends and research projects making news in the vaccine field. | |
| Audience: | Senior pharmaceutical and biotech executives, researchers, and others focused on developing the vaccines of the future. | |
| Channels: | Weekly email newsletter, Website, Webinars, Events | |
| Email Subscribers: | 5,000+ | |
| Lead Editor: | John D. Carroll |
